Optina Diagnostics raises $4 mln for early detection of Alzheimer’s
Optina Diagnostics Inc, a Montréal-based developer of an eye scan for early detection of Alzheimer's, has raised $4 million in a seed-stage financing. Zoic Capital, a U.S. medical device venture capital firm, led the round. It was joined by Desjardins Capital, DigitalDx Ventures, Pallasite Ventures, Barney Pell, Barney Pell's AngelList Syndicate, Advisors.fund and Hike Ventures. Optina uses artificial intelligence and spectral retinal imaging to detect Alzheimer's disease in order to treat it in patients before irreversible damage occurs. The company, led by CEO David Lapointe, will use the funds raised to advance clinical development and accelerate growth and market readiness.
10 October 2018•4 mins read
